These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38721918)

  • 1. Pan-Enteric Crohn's Capsule [Eliakim] Score Reliability and Responsiveness to Change in Active Crohn's Disease.
    Ukashi O; Lahat A; Ungar B; Levy H; Finkel O; Eidler P; Ben-Horin S; Eliakim R; Kopylov U
    J Crohns Colitis; 2024 Oct; 18(10):1622-1630. PubMed ID: 38721918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel PillCam Crohn's capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn's disease.
    Eliakim R; Yablecovitch D; Lahat A; Ungar B; Shachar E; Carter D; Selinger L; Neuman S; Ben-Horin S; Kopylov U
    United European Gastroenterol J; 2020 Jun; 8(5):544-551. PubMed ID: 32213037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn's Disease Activity Index.
    Koulaouzidis A; Douglas S; Plevris JN
    Dig Dis Sci; 2012 Apr; 57(4):987-93. PubMed ID: 22057284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease.
    Omori T; Kambayashi H; Murasugi S; Ito A; Yonezawa M; Nakamura S; Tokushige K
    Dig Dis Sci; 2020 Apr; 65(4):1180-1188. PubMed ID: 31541367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning and minimally invasive inflammatory activity assessment: a proof-of-concept study for development and score correlation of a panendoscopy convolutional network.
    Cardoso P; Mascarenhas M; Afonso J; Ribeiro T; Mendes F; Martins M; Andrade P; Cardoso H; Mascarenhas Saraiva M; Ferreira JPS; Macedo G
    Therap Adv Gastroenterol; 2024; 17():17562848241251569. PubMed ID: 38812708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of capsule endoscopy Lewis score with clinical disease activity indices, C-reactive protein, and small bowel transit time in pediatric and adult patients with small bowel Crohn's disease.
    He C; Zhang J; Chen Z; Feng X; Luo Z; Wan T; Li A; Liu S; Ren Y
    Medicine (Baltimore); 2017 Aug; 96(33):e7780. PubMed ID: 28816962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of capsule endoscopy in the phenotype of Crohn's disease. Data from England 2016-2021.
    Oka P; Vibhishanan S; Chetcuti Zammit S; Sidhu R
    Arab J Gastroenterol; 2024 Aug; 25(3):288-292. PubMed ID: 39048386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
    Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
    Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease.
    Monteiro S; Barbosa M; Cúrdia Gonçalves T; Boal Carvalho P; Moreira MJ; Rosa B; Cotter J
    Inflamm Bowel Dis; 2018 Aug; 24(9):2033-2038. PubMed ID: 29722829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsule Endoscopy Validation of the Magnetic Enterography Global Score in Patients with Established Crohn's Disease.
    Klang E; Amitai MM; Lahat A; Yablecovitch D; Avidan B; Neuman S; Levhar N; Rozendorn N; Weiss B; Ben-Horin S; Eliakim R; Kopylov U;
    J Crohns Colitis; 2018 Feb; 12(3):313-320. PubMed ID: 29182750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.
    Mitselos IV; Katsanos KH; Tatsioni A; Skamnelos A; Eliakim R; Tsianos EV; Christodoulou DK
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):861-867. PubMed ID: 29697457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.
    Makanyanga JC; Pendsé D; Dikaios N; Bloom S; McCartney S; Helbren E; Atkins E; Cuthbertson T; Punwani S; Forbes A; Halligan S; Taylor SA
    Eur Radiol; 2014 Feb; 24(2):277-87. PubMed ID: 24026620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
    BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
    Khanna R; Nelson SA; Feagan BG; D'Haens G; Sandborn WJ; Zou GY; MacDonald JK; Parker CE; Jairath V; Levesque BG
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010642. PubMed ID: 27501379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin in predicting small bowel capsule endoscopy findings in pediatric patients with known Crohn's disease.
    Wang S; Miao S; Qiu X; Wu J; Wang Y
    Medicine (Baltimore); 2022 Oct; 101(42):e31163. PubMed ID: 36281159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.